Harnessing the power of Artificial Intelligence to unlock further potential of known drugs for orphan diseases

We leverage the power of Artificial Intelligence to repurpose drugs for orphan diseases

We are a team of talented scientists with a passion for innovation

Learn about us

STANDARD DRUG DISCOVERY AND DEVELOPMENT

WE CAN REDUCE THOSE NUMBERS TO

OUR APPROACH

PROPRIETARY PIPELINE

PARTNERSHIP

OUR PERFORMANCE INDICATORS

WE COOPERATE WITH

SOM BIOTECH IN THE MEDIA

LATEST NEWS

SOM Biotech at the 10th Drug Discovery Innovation Programme

November 29, 2019
SOM Biotech participated in the 10th Drug Discovery Innovation Programme that took place on November 28th -29th- in Barcelona, Spain. Luca Signorile – Computational Chemist of SOM Biotech –performed the presentation on the topic “Re-Discovering Drugs: Advantages, Perspectives, and the role of AI.” During his speech, he gave an insight into the computational side of…

SOM Biotech at the Clinical Trials Europe 2019 conference

November 27, 2019
SOM Biotech has participated in the “Clinical Trials Europe 2019” conference, that took place on November 19th -21st- in Barcelona, Spain. The “Clinical Trials Europe 2019”, one of the leading platforms to build partnerships to develop clinical trials, attracts a wide range of innovative research centers and business development teams from biotech and pharma companies.…

SOM Biotech at the 10th World Orphan Drug Congress 2019

November 15, 2019
SOM Biotech participated in the World Orphan Drug Congress Europe 2019 on November 12th -14th- in Barcelona, Spain, where the company was a Showcase Sponsor. Raul Insa – CEO of SOM Biotech – presented “Case study: Systematic drug re-innovation and clinical evidence in orphan diseases”. SOM Biotech shared its latest findings in drug discovery and…

SOM Biotech at European Conference on Recent Advances in Lysosomal Diseases

November 4, 2019
Gal·la Pericot, R&D Manager at SOM Biotech, attended the European Conference on Recent Advances in Lysosomal Diseases, which took place on 24-25 October 2019 in London, UK. The main objective of the conference was sharing of innovative knowledge on the development of new therapeutic modalities for treating disorders linked to the lysosomal storage in the cells,…

SOM Biotech at Bio-Europe 2019

October 24, 2019
SOM Biotech will participate in the 25th Annual International Partnering Conference “Bio-Europe” on November 10th -13th- in Hamburg, Germany. The conference, Europe´s largest life science partnering venue, is one of the most relevant events to meet with world-leading life science partners, investors, and industry experts. Raul Insa – CEO of SOM Biotech – and Maria…

SOM Biotech at the 19th Annual Schrödinger European User Group Meeting

October 22, 2019
Luca Signorile, the Senior Computational Chemist at SOM Biotech, participated in the 19th Annual Schrödinger European User Group Meeting, that took place in Berlin on September 25th-27th. The Meeting aimed at illustrating how the capabilities of the Schrödinger software can be efficiently applied to drug discovery to increase research productivity. Science and Technology are the…